Literature DB >> 34223649

Differential effects of estradiol and progesterone on human T cell activation in vitro.

Georgia Papapavlou1, Sandra Hellberg2, Johanna Raffetseder1, Jan Brynhildsen3,4, Mika Gustafsson2, Maria C Jenmalm1, Jan Ernerudh5.   

Abstract

Estradiol (E2) and progesterone (P4) are steroid hormones important for the regulation of immune responses during pregnancy. Their increasing levels coincide with an improvement of T cell-mediated diseases such as multiple sclerosis (MS). Although immune-endocrine interactions are involved in this phenomenon, the relative contribution of hormones is not known. We here report a direct comparison of E2- and P4-mediated effects on human CD4+ T cells, key cells in immune regulation. T cells were stimulated to obtain different activation levels and exposed to a broad range of hormone concentrations. Activation level was assessed by CD69/CD25 expression by flow cytometry, and secreted proteins (n = 196) were measured in culture supernatants using proximity extension assay and electrochemiluminescence immunoassay. We found that in low activated cells, pregnancy-relevant E2 concentrations increased activation and the secretion of several immune- and inflammation-related proteins. P4, on the other hand, showed a biphasic pattern, where serum-related concentrations upregulated activation and protein secretion while placenta-relevant concentrations induced a prominent dampening irrespective of the initial activation level. Our results demonstrate the importance of P4 as a major hormone in the immune modulation of T cells during pregnancy and emphasize the need to further evaluate its potency in the treatment of diseases like MS.
© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Entities:  

Keywords:  CD4+ T cell activation; estrogen; human; progesterone; proteomics

Mesh:

Substances:

Year:  2021        PMID: 34223649     DOI: 10.1002/eji.202049144

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Improving Glucocorticoid Sensitivity of Brain-Homing CD4+ T Helper Cells by Steroid Hormone Crosstalk.

Authors:  Steven C Koetzier; Jamie van Langelaar; Annet F Wierenga-Wolf; Marie-José Melief; Kim Pol; Suzanne Musters; Erik Lubberts; Willem A Dik; Joost Smolders; Marvin M van Luijn
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  Progesterone Inhibits the Establishment of Activation-Associated Chromatin During TH1 Differentiation.

Authors:  Olof Rundquist; Colm E Nestor; Maria C Jenmalm; Sandra Hellberg; Mika Gustafsson
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

3.  Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus.

Authors:  Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh; Ju-Yang Jung
Journal:  Front Med (Lausanne)       Date:  2022-08-11

4.  Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.

Authors:  Georgia Papapavlou Lingehed; Sandra Hellberg; Jesse Huang; Mohsen Khademi; Ingrid Kockum; Hanna Carlsson; Ivar Tjernberg; Maria Svenvik; Jonas Lind; Marie Blomberg; Magnus Vrethem; Johan Mellergård; Mika Gustafsson; Maria C Jenmalm; Tomas Olsson; Jan Ernerudh
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 5.  Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation.

Authors:  Tatiana A Fedotcheva; Nadezhda I Fedotcheva; Nikolai L Shimanovsky
Journal:  Biomolecules       Date:  2022-09-14

6.  High-progesterone environment preserves T cell competency by evading glucocorticoid effects on immune regulation.

Authors:  Hirofumi Kashiwagi; Toshiro Seki; Shino Oshima; Yusuke Ohno; Tomoka Shimizu; Soga Yamada; Nagi Katano; Yumiko Goto; Atsushi Yasuda; Banri Tsuda; Ryoji Ito; Shun-Ichiro Izumi; Hitoshi Ishimoto; Takashi Shiina; Yoshie Kametani
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.